RCSB PDB - 6GOF: KRAS full length G12D GPPNHP
Sequences of synthetic guide RNA (sgRNA) targeting Kras G12D . | Download Scientific Diagram
KRAS mutation detection in CD45 depleted blood. The KRAS G12D mutation... | Download Scientific Diagram
KRAS G12D can be targeted by potent salt-bridge forming inhibitors | bioRxiv
KRAS - Wikipedia
Silencing of oncogenic KRAS by mutant-selective small interfering RNA Bjoern Papke1, Salma H. Azam1,2, Anne Y. Feng1, Amanda E.
KRAS Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Sequencing electropherogram of KRAS exon 2. (A) Wild-type. (B) G12D... | Download Scientific Diagram
Selective targeting of point-mutated KRAS through artificial microRNAs | PNAS
KRAS G12D Reference Standard, 5%
KRAS mutation analysis (direct sequencing) of codon 12 of exon 2. (A)... | Download Scientific Diagram
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D | PNAS
Oncogenic G12D mutation alters local conformations and dynamics of K-Ras | Scientific Reports
Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid‑based antisense: A potential new drug candidate for pancreatic cancer
Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity
sequencing electropherogram of KRAS gene exon 1: (A) g12D mutation; (B)... | Download Scientific Diagram
Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification | PLOS ONE
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Exploiting TCR affinity for therapeutic targeting of neoantigens
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis. - Abstract - Europe PMC
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Genetically-engineered mouse models for pancreatic cancer: Advances and current limitations
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D | PNAS
